News

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
The Trump administration is reportedly preparing to withdraw the COVID-19 vaccines from the U.S. market within the coming ...
The DOJ interviewed Maxwell as part of its scramble to regain the public’s trust after botching the rollout of the Epstein files. After Attorney General Pam Bondi promised the release of Epstein’s ...
The COVID-19 BNT162b2 vaccine was protective against COVID-19-associated hospitalization for the 2024 to 2025 season among immunocompetent adults.
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...
The CDC has already changed some vaccine guidelines, and the FDA may change others, which could throw insurance coverage into ...
The American Academy of Pediatrics has provided vaccine recommendations and published its own vaccine schedule for nearly 100 years.
Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...